Melanoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
Condition:   Metastatic Uveal Melanoma Interventions:   Drug: IDE196;   Drug: Crizotinib;   Drug: Pembrolizumab;   Drug: Ipilimumab;   Drug: Nivolumab;   Drug: Dacarbazine Sponsor:   IDEAYA Biosciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma
Condition:   Melanoma (Skin) Interventions:   Drug: BCD-201;   Drug: Keytruda Sponsor:   Biocad Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
Condition:   Metastatic Uveal Melanoma Interventions:   Drug: IDE196;   Drug: Crizotinib;   Drug: Pembrolizumab;   Drug: Ipilimumab;   Drug: Nivolumab;   Drug: Dacarbazine Sponsor:   IDEAYA Biosciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma
Condition:   Melanoma (Skin) Interventions:   Drug: BCD-201;   Drug: Keytruda Sponsor:   Biocad Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
Condition:   Metastatic Uveal Melanoma Interventions:   Drug: IDE196;   Drug: Crizotinib;   Drug: Pembrolizumab;   Drug: Ipilimumab;   Drug: Nivolumab;   Drug: Dacarbazine Sponsor:   IDEAYA Biosciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma
Condition:   Melanoma (Skin) Interventions:   Drug: BCD-201;   Drug: Keytruda Sponsor:   Biocad Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials

Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Condition:   Melanoma Intervention:   Drug: Fluzoparib Camrelizumab Temozolomide Sponsor:   Jun Guo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System
Conditions:   Meningeal Melanocytoma;   Meningeal Melanomatosis;   Meningeal Melanocytosis;   Meningeal Melanoma Intervention:   Sponsor:   Central Hospital, Nancy, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials